Canaccord Genuity analyst Michael Graham reiterated a Buy rating and $65.00 price target on DraftKings Inc. (NASDAQ: DKNG) following the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Benchmark Reiterates Buy Rating on DraftKings Inc. (DKNG)November 16, 2020 7:33 AM Needham Pounds the Table on DraftKings Inc. (DKNG) Buy, Raises EstimatesNovember 16, 2020 7:27 AM DraftKings Inc. (DKNG) PT Lowered to $46 at Deutsche BankNovember 16, 2020 7:02 AM DraftKings Inc. (DKNG) PT Raised to $39 at Morgan StanleyNovember 16, 2020 6:46 AM Fintech, E-Sports, Sports Betting, and E-Commerce, and the Cloud: Global Leaders of Alibaba, Peak Fintech, FansUnite and DraftKings Driving Revenue Growth As Digital Transformation AcceleratesNovember 13, 2020 11:07 AM Increasing option volume: DKNG LI ZM PFE PLUGNovember 13, 2020 9:45 AM Pre-Open Stock Movers 11/13: (LI) (FTCH) (DKNG) Higher; (SFT) (SAVA) (BLNK) Lower (more...)November 13, 2020 9:27 AM DraftKings (DKNG) Q3 Revenue Tops Consensus, Raises FY20 Revenue Guidance and Issues FY21November 13, 2020 7:03 AM DraftKings Reports Third Quarter Results and Raises 2020 Revenue GuidanceNovember 13, 2020 7:00 AM DraftKings Reports Third Quarter Results and Raises 2020 Revenue GuidanceNovember 13, 2020 7:00 AM DraftKings (DKNG) calls more active than puts into quarter results and outlookNovember 12, 2020 10:05 AM Cano Health to list via $4.4 billion merger with Barry Sternlicht-backed SPACNovember 12, 2020 8:07 AM